700 related articles for article (PubMed ID: 26683498)
21. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
[TBL] [Abstract][Full Text] [Related]
22. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
[TBL] [Abstract][Full Text] [Related]
23. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
24. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
[TBL] [Abstract][Full Text] [Related]
25. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
[TBL] [Abstract][Full Text] [Related]
26. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
28. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.
Nagino M; Nimura Y; Nishio H; Ebata T; Igami T; Matsushita M; Nishikimi N; Kamei Y
Ann Surg; 2010 Jul; 252(1):115-23. PubMed ID: 20531001
[TBL] [Abstract][Full Text] [Related]
29. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
[TBL] [Abstract][Full Text] [Related]
31. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
[TBL] [Abstract][Full Text] [Related]
32. Major hepatectomy for perihilar cholangiocarcinoma.
Unno M; Katayose Y; Rikiyama T; Yoshida H; Yamamoto K; Morikawa T; Hayashi H; Motoi F; Egawa S
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):463-9. PubMed ID: 19941010
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
[TBL] [Abstract][Full Text] [Related]
34. One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study.
Tan JW; Hu BS; Chu YJ; Tan YC; Ji X; Chen K; Ding XM; Zhang A; Chen F; Dong JH
World J Surg; 2013 Mar; 37(3):614-21. PubMed ID: 23283218
[TBL] [Abstract][Full Text] [Related]
35. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
36. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
[TBL] [Abstract][Full Text] [Related]
37. The DNA index as a prognostic tool in hilar cholangiocarcinoma.
Kamphues C; Al-Abadi N; Bova R; Rademacher S; Al-Abadi H; Klauschen F; Bahra M; Neuhaus P; Pratschke J; Seehofer D
J Surg Oncol; 2015 Aug; 112(2):214-8. PubMed ID: 26220797
[TBL] [Abstract][Full Text] [Related]
38. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
[TBL] [Abstract][Full Text] [Related]
39. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.
Thelen A; Scholz A; Weichert W; Wiedenmann B; Neuhaus P; Gessner R; Benckert C; Jonas S
Am J Gastroenterol; 2010 May; 105(5):1123-32. PubMed ID: 19997097
[TBL] [Abstract][Full Text] [Related]
40. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]